Moolec Science SA (MLEC)
1.22
+0.02
(+1.67%)
USD |
NASDAQ |
May 17, 16:00
1.22
0.00 (0.00%)
After-Hours: 20:00
Moolec Science Free Cash Flow (Quarterly): -3.897M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.897M |
| September 30, 2023 | -1.848M |
| June 30, 2023 | -2.695M |
| Date | Value |
|---|---|
| March 31, 2023 | -4.346M |
| December 31, 2022 | -0.6591M |
| September 30, 2022 | 0.0096M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.346M
Minimum
Mar 2023
0.0096M
Maximum
Sep 2022
-2.239M
Average
-2.272M
Median
Free Cash Flow (Quarterly) Benchmarks
| Alvotech | -77.62M |
| Procaps Group SA | 39.71M |
| Sunshine Biopharma Inc | -2.993M |
| Bio-Path Holdings Inc | -1.814M |
| Palisade Bio Inc | -3.18M |